<DOC>
	<DOC>NCT00151814</DOC>
	<brief_summary>Determine single dose pharmacokinetic parameters of olmesartan in pediatric patients with hypertension in ages 12 months - 16 years</brief_summary>
	<brief_title>Olmesartan Pediatric Pharmacokinetic (PK) Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<criteria>Age 12 months to 16 years inclusive Signed parental/guardian informed consent and assent from the subject Current treatment for hypertension, or, if not currently treated for hypertension, systolic blood pressure (SBP) greater than or equal to 95th percentile for gender and heightforage, or, if not currently treated for hypertension, systolic blood pressure or diastolic blood pressure greater than or equal to 90th percentile for gender and heightforage and diabetic or having a family history of hypertension Glomerular filtration rate (GFR) greater than or equal to 30 mL/min/1.73 m2, estimated using the Schwartz equation Sexually active females of childbearing potential must be practicing an acceptable method of birth control Negative serum betahuman chorionic gonadotropin at screening and at admission (female of childbearing potential only) Clinically significant cardiac, gastrointestinal, hematologic, hepatic or hepatobiliary, neurologic, or pulmonary (except asthma) disorder History of severe or symptomatic hypertension associated with stroke, seizures, encephalopathy, or other significant neurologic findings within 1 year prior to screening Current treatment with more than 2 antihypertensive medications Secondary hypertension from uncorrected coarctation of the aorta, bilateral renal artery stenosis, or unilateral renal artery stenosis in a single kidney Serum albumin &lt; 2.5 g/dL Major organ or bone marrow transplantation except for prior kidney transplantation of at least 6 months and with stable renal function meeting the inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Olmesartan PK in children</keyword>
</DOC>